BioCorRx Inc.
2390 East Orangewood Avenue
Suite 575
Anaheim, California 92086
September 7, 2018
VIA EDGAR
U.S. Securities & Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Re: | BioCorRx Inc. |
| Registration Statement on Form S-1 | |
| File No. 333-227009 |
Ladies and Gentlemen:
In accordance with Rule 461 of the Securities Act of 1933, as amended, BioCorRx Inc. (the “Company”) hereby respectfully requests that the effective date of the above-captioned Registration Statement be accelerated so that it will be declared effective at 5:00 p.m. Eastern Time on Wednesday, September 12, 2018, or as soon thereafter as possible.
* * * *
Very Truly Yours,
BioCorRx Inc. | |
| |
/s/ Brady Granier |
|
Brady Granier |
|
President and Chief Executive Officer |